Search Results 2821-2830 of 24014 for GI

  1. A Study to Examine Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia - Mayo Clinic

    Organ AVM (lung, brain, liver, renal, spinal or limb AVMs or GI telangiectasia);; An affected first-degree relative by same criteria. Genetic diagnosis of ...

  2. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fruquintinib in Patients with Solid Tumors - Mayo Clinic

    ... gastrointestinal tract hemorrhage or perforation. History or presence of ... gastrointestinal disease, or any other condition that investigators ...

  3. Contact - Mayo Clinic Research

    ... gastrointestinal disease in children, gastrointestinal disease in pregnancy and more. Explore all Mayo Clinic studies. You can browse trials categorized by ...

  4. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    Neurogastroenterologist. Jacksonville, FL. Areas of focus: Bravo capsule pH test, Upper endoscopy, Colonoscopy, Gastrointestinal transit study, Esophageal ...

  5. Rectal cancer surgery - Doctors & Departments - Mayo Clinic

    Early-Onset and Hereditary GI Cancers Program · Early-Onset Colorectal Cancer ... Gastrointestinal and Endoscopic Surgeons. Surgical Endoscopy. 2023; doi ...

  6. Acrivastine and pseudoephedrine (oral route) - Mayo Clinic

    Pseudoephedrine is a decongestant, which decreases nasal congestion by narrowing the blood vessels and reducing blood flow to the nasal passage. This medicine ...

  7. Parkinson's Disease Clinical Trials - Mayo Clinic Research

    ... GI motor and barrier functions and with submucosal neuronal dopamine and αS expression in patients with PD with GI symptoms. Weight Loss in Parkinson's ...

  8. Trichuris Suis Ova Treatment In Left-sided Ulcerative Colitis - Mayo Clinic

    Uncontrolled GI bleeding; Subjects who have disease limited to the rectum ... Gastrointestinal parasites: potential therapy for refractory inflammatory bowel ...

  9. Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant - Mayo Clinic

    Participant has impairment of gastrointestinal (GI) function or GI disease that may significantly alter the absorption of the study drugs (e.g., ulcerative ...

  10. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, And The Combinations Of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) In Women With Recurrent, Persistent Or Metastatic Endometrial Cancer. A Multi-Arm Trial For Women With Recurrent Or Persistent Endometrial Cancer” - Mayo Clinic

    ... gastrointestinal mucosa; Note: patients on this non-cytotoxic study are allowed to receive one additional cytotoxic chemotherapy regimen for management of ...